story of the week
Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma: The SAVOIR Phase 3 Randomized Clinical Trial
JAMA Oncol 2020 May 29;[EPub Ahead of Print], TK Choueiri, DYC Heng, JL Lee, M Cancel, RB Verheijen, A Mellemgaard, LH Ottesen, MM Frigault, A L'Hernault, Z Szijgyarto, S Signoretti, L AlbigesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.